{"altmetric_id":7136138,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"total":{"posts_count":12},"news":{"unique_users_count":1,"unique_users":["my_news_desk"],"posts_count":1},"twitter":{"unique_users_count":10,"unique_users":["FrontOncology","VEGFRSSfeeds","chioseasi","HumanPathology","tissuedetective","theslimmingdoc","mvmd0908","gizbab","pembeoltulu","DoctorsOverseas"],"posts_count":10},"reddit":{"unique_users_count":1,"unique_users":["montaukwhaler"],"posts_count":1}},"selected_quotes":["1-12% of lung adenoca (like this one) harbor RET rearrangements","-12% of lung adenoca (like this one) harbor RET rearrangements"],"citation":{"abstract":"Lung adenocarcinoma is the most common subtype of non-small cell lung cancer (NSCLC). With the discovery of epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) rearrangements, and effective targeted therapies, therapeutic options are expanding for patients with lung adenocarcinoma. Here, we review novel therapies in non-squamous NSCLC, which are directed against oncogenic targets, including EGFR, ALK, ROS1, BRAF, MET, human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor receptor 2 (VEGFR2), RET, and NTRK. With the rapidly evolving molecular testing and development of new targeted agents, our ability to further personalize therapy in non-squamous NSCLC is rapidly expanding.","altmetric_jid":"4f6fa90f3cf058f61000cc4f","authors":["Bansal, Pranshu","Osman, Diaa","Gan, Gregory N.","Simon, George R.","Boumber, Yanis","Gan, Gregory N","Simon, George R","Pranshu Bansal","Diaa Osman","Gregory N. Gan","George R. Simon","Yanis Boumber"],"doi":"10.3389\/fonc.2016.00112","first_seen_on":"2016-05-04T04:49:24+00:00","funders":["niehs"],"issns":["2234-943X"],"journal":"Frontiers in oncology","last_mentioned_on":1476143743,"links":["http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2016.00112\/full?utm_source=twitterfeed&utm_medium=twitter","http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2016.00112\/full","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27200298?dopt=Abstract&utm_source=twitterfeed&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4854869\/pdf\/fonc-06-00112.pdf","https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4854869\/pdf\/fonc-06-00112.pdf"],"pdf_url":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2016.00112\/pdf","pmcid":"PMC4854869","pmid":"27200298","pubdate":"2016-05-04T00:00:00+00:00","publisher":"Frontiers","title":"Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC","type":"article","uri":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2016.00112\/abstract","volume":"6","mendeley_url":"http:\/\/www.mendeley.com\/research\/recent-advances-targetable-therapeutics-metastatic-nonsquamous-nsclc"},"altmetric_score":{"score":11.2,"score_history":{"1y":1,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":11.2},"context_for_score":{"all":{"total_number_of_other_articles":8451184,"mean":7.1040239874029,"rank":784817,"this_scored_higher_than_pct":90,"this_scored_higher_than":7664881,"rank_type":"exact","sample_size":8451184,"percentile":90},"similar_age_3m":{"total_number_of_other_articles":271973,"mean":11.584120291794,"rank":36105,"this_scored_higher_than_pct":86,"this_scored_higher_than":235799,"rank_type":"exact","sample_size":271973,"percentile":86},"this_journal":{"total_number_of_other_articles":1614,"mean":2.4874606323621,"rank":60,"this_scored_higher_than_pct":96,"this_scored_higher_than":1554,"rank_type":"exact","sample_size":1614,"percentile":96},"similar_age_this_journal_3m":{"total_number_of_other_articles":86,"mean":1.762,"rank":1,"this_scored_higher_than_pct":98,"this_scored_higher_than":85,"rank_type":"exact","sample_size":86,"percentile":98}}},"demographics":{"poster_types":{"member_of_the_public":5,"researcher":1,"practitioner":4},"users":{"twitter":{"cohorts":{"Members of the public":5,"Practitioners (doctors, other healthcare professionals)":4,"Scientists":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":5,"Student  > Ph. D. Student":2,"Student  > Postgraduate":1,"Student  > Master":1,"Student  > Bachelor":3},"by_discipline":{"Medicine and Dentistry":4,"Agricultural and Biological Sciences":7,"Biochemistry, Genetics and Molecular Biology":3}}},"geo":{"twitter":{"CH":1,"US":2,"FR":1,"TR":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/FrontOncology\/statuses\/727721693502935040","license":"gnip","citation_ids":[7136138],"posted_on":"2016-05-04T04:49:06+00:00","author":{"name":"Frontiers Oncology","url":"http:\/\/frontiersin.org\/Oncology","image":"https:\/\/pbs.twimg.com\/profile_images\/533293709106741248\/5mXWKHdV_normal.jpeg","description":"The official Twitter Feed for all the latest open-access, peer-reviewed articles in Frontiers in Oncology.","id_on_source":"FrontOncology","tweeter_id":"397385515","geo":{"lt":46.516,"ln":6.63282,"country":"CH"},"followers":984},"tweet_id":"727721693502935040"},{"url":"http:\/\/twitter.com\/VEGFRSSfeeds\/statuses\/733980248249765888","license":"gnip","citation_ids":[7136138],"posted_on":"2016-05-21T11:18:22+00:00","author":{"name":"VEGF RSS Feeds","image":"https:\/\/pbs.twimg.com\/profile_images\/516588600\/VEGF_normal.jpg","id_on_source":"VEGFRSSfeeds","tweeter_id":"88511740","geo":{"lt":null,"ln":null},"followers":363},"tweet_id":"733980248249765888"},{"url":"http:\/\/twitter.com\/chioseasi\/statuses\/766637971286134784","license":"gnip","citation_ids":[3858590,7136138],"posted_on":"2016-08-19T14:08:30+00:00","author":{"name":"Simon Chiosea, MD","url":"http:\/\/path.upmc.edu\/Personnel\/Faculty\/Chiosea.htm","image":"https:\/\/pbs.twimg.com\/profile_images\/692009913531420672\/DnU_R-JI_normal.jpg","description":"Head & Neck and Molecular Pathologist. History of Medicine. T\/RT\u2260 medical advice. http:\/\/bit.ly\/1S0xUPZ #ENTPath @ArchivesPath","id_on_source":"chioseasi","tweeter_id":"4765402322","geo":{"lt":40.44062,"ln":-79.99589,"country":"US"},"followers":3003},"tweet_id":"766637971286134784"},{"url":"http:\/\/twitter.com\/HumanPathology\/statuses\/766651043421818880","license":"gnip","rt":["chioseasi"],"citation_ids":[3858590,7136138],"posted_on":"2016-08-19T15:00:27+00:00","author":{"name":"Human Pathology","url":"http:\/\/humpath.com","image":"https:\/\/pbs.twimg.com\/profile_images\/566655604366643201\/4V2YSeun_normal.jpeg","description":"This Twitter is dedicated to human pathology and maintained by @jcfournet, surgical and molecular pathologist in Paris, France.","id_on_source":"HumanPathology","tweeter_id":"26601124","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":9153},"tweet_id":"766651043421818880"},{"url":"http:\/\/twitter.com\/tissuedetective\/statuses\/766651169070518272","license":"gnip","rt":["chioseasi"],"citation_ids":[3858590,7136138],"posted_on":"2016-08-19T15:00:57+00:00","author":{"name":"Ali  Y.  Hashim, MD.","image":"https:\/\/pbs.twimg.com\/profile_images\/702925153752068096\/uQW2YpCZ_normal.jpg","description":"The anatomical pathologists are the tissue & cell detectives, & the invisible doctors who visualize science & medicine.","id_on_source":"tissuedetective","tweeter_id":"2725648692","geo":{"lt":null,"ln":null},"followers":1142},"tweet_id":"766651169070518272"},{"url":"http:\/\/twitter.com\/theslimmingdoc\/statuses\/766720557203283969","license":"gnip","rt":["chioseasi"],"citation_ids":[3858590,7136138],"posted_on":"2016-08-19T19:36:40+00:00","author":{"name":"theslimmingdoc","image":"https:\/\/pbs.twimg.com\/profile_images\/735905513553154049\/N_N9OWAT_normal.jpg","description":"Medic\/dentist, ex surgeon, pathology registrar. Passionate about a sustainable NHS. I'm also interested in genomic medicine and molecular pathology.","id_on_source":"theslimmingdoc","tweeter_id":"1648533510","geo":{"lt":null,"ln":null},"followers":215},"tweet_id":"766720557203283969"},{"url":"http:\/\/twitter.com\/mvmd0908\/statuses\/766802295661006848","license":"gnip","rt":["chioseasi"],"citation_ids":[3858590,7136138],"posted_on":"2016-08-20T01:01:28+00:00","author":{"name":"Pathology","image":"https:\/\/pbs.twimg.com\/profile_images\/3701221689\/4fecd7c62afe6ce7715060e9d6f876a1_normal.jpeg","description":"Dermatopathologist Tweets are not medical advice RT is not endorsement #dermpath #pathology #pathologists","id_on_source":"mvmd0908","tweeter_id":"1444165801","geo":{"lt":null,"ln":null},"followers":5595},"tweet_id":"766802295661006848"},{"url":"http:\/\/twitter.com\/gizbab\/statuses\/766803758500159488","license":"gnip","rt":["chioseasi"],"citation_ids":[3858590,7136138],"posted_on":"2016-08-20T01:07:17+00:00","author":{"name":"Ronald Przygodzki","image":"https:\/\/pbs.twimg.com\/profile_images\/858736374270373888\/sUborohY_normal.jpg","description":"working to find ways to make life better for others through good medical science","id_on_source":"gizbab","tweeter_id":"1330325672","geo":{"lt":38.91706,"ln":-77.00025,"country":"US"},"followers":317},"tweet_id":"766803758500159488"},{"url":"http:\/\/twitter.com\/pembeoltulu\/statuses\/766909981962674176","license":"gnip","rt":["chioseasi"],"citation_ids":[3858590,7136138],"posted_on":"2016-08-20T08:09:22+00:00","author":{"name":"Pembe Oltulu, MD","image":"https:\/\/pbs.twimg.com\/profile_images\/866414373589450752\/NGP3ENJz_normal.jpg","description":"Pathologist (Assist Prof) in Meram faculty of medicine,#dermpath,#eyepath, interactiv Med editor @HeadNeckPathol,married,have four children,T\/RT\u2260 medical advice","id_on_source":"pembeoltulu","tweeter_id":"2891257500","geo":{"lt":38.16667,"ln":32.5,"country":"TR"},"followers":3310},"tweet_id":"766909981962674176"},{"url":"http:\/\/twitter.com\/DoctorsOverseas\/statuses\/785629918893776897","license":"gnip","citation_ids":[3858590,7136138],"posted_on":"2016-10-10T23:55:43+00:00","author":{"name":"Doctors Overseas","image":"https:\/\/pbs.twimg.com\/profile_images\/516781570510696449\/Nz_sR4Kl_normal.jpeg","description":"Helping others means to render aid and comfort wherever it may be needed, because when a person is down an ounce of help is  better than a pound of preaching...","id_on_source":"DoctorsOverseas","tweeter_id":"2416566847","geo":{"lt":null,"ln":null},"followers":2006},"tweet_id":"785629918893776897"}],"reddit":[{"title":"Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC","url":"http:\/\/www.reddit.com\/r\/nsclc\/comments\/4hym7t\/recent_advances_in_targetable_therapeutics_in\/","license":"public","citation_ids":[7136138],"posted_on":"2016-05-05T05:39:43+00:00","author":{"name":"montaukwhaler","url":"http:\/\/www.reddit.com\/r\/nsclc","id_on_source":"nsclc","followers":1,"subreddit":"non small cell lung cancer"}}],"news":[{"title":"Novartis presenterar framsteg inom icke sm\u00e5cellig lungcancer","url":"http:\/\/ct.moreover.com\/?a=26818322575&p=1pl&v=1&x=iQPZ6YQfIX5qrJQMDK-3Zg","license":"public","citation_ids":[4687347,8573443,8573446,7136138,6791850],"posted_on":"2016-06-08T05:37:00+00:00","summary":"I samband med den internationella cancerkonferensen 52 nd Annual Meeting of the American Society of Clinical Oncology, ASCO i Chicago, presenterar Novartis data f\u00f6r tv\u00e5 olika m\u00e5linriktade terapier mot olika former av icke sm\u00e5cellig lungcancer, NSCLC.","author":{"name":"My News Desk","url":"http:\/\/www.mynewsdesk.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/847\/normal\/Screen_Shot_2016-01-27_at_11.32.34.png?1453894453"}}]}}